Blocking glycogen, a key energy source, could slow or prevent ovarian cancer spread
In nearly 80 percent of women with ovarian cancer, the disease has already spread to…
Browsing: ovarian cancer
INNOVATE phase II results demonstrate combination of tumour treating fields with paclitaxel may improve survival of patients with recurrent ovarian cancer
The results of its INNOVATE phase 2 pilot trial have been published in Gynecologic Oncology.…
Large population study fails to find causal link between assisted reproduction and ovarian cancer
Following concerns over many years that hormonal stimulation of the ovaries necessary for IVF may…
Researchers apply computing power to track the spread of cancer
Princeton researchers have developed a new computational method that increases the ability to track the…
“Serendipitous” use of antimalarial drug may have improved outcome for a patient with ovarian cancer
A cancer patient with advanced ovarian cancer had a “remarkable” journey to recovery that may…
Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including…
Chemotherapy timing could influence how well the treatment works
Yanyan Yang, University of North Carolina – Chapel Hill and Aziz Sancar, University of North…
Scientists identify cause of resistance to breakthrough breast and ovarian cancer drug
Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment…
ANZGOG 2018: Challenges in Precision Gynaecological Cancer in a Molecular Era
Review of the ANZGOG Annual Scientific Meeting 2018 The Annual Scientific Meeting (ASM) of the…
Personalised tumour vaccine shows promise in pilot trial
A new type of cancer vaccine has yielded promising results in an initial clinical trial…